Despite being at the front lines in the nation’s battle against opioid addiction as the first to treat chronic pain, and opioid overuse, few primary care and family physicians use the one drug available to them to treat addiction, buprenorphine, experts say. “Sublingual buprenorphine is the only treatment for opioid addiction that can be provided […]
Read MoreThe Centers for Disease Control and Prevention (CDC) has broadened its recommendation about giving docusate to patients as it continues to investigate a multistate outbreak of Burkholderia cepacia complex infections, which began in ventilated patients in the intensive care unit. To date, 47 B. cepacia complex cases have been confirmed to match one of two outbreak strains identified from […]
Read MoreTwenty minutes may be all it takes to identify a case of acetaminophen (APAP) poisoning, according to the developers of a new test for the condition that, they say, could streamline treatment for patients with liver failure related to the drug. In a recent study, the 20-minute test (AcetaSTAT, Acetaminophen Toxicity Diagnostics) was performed as […]
Read MoreNeurologists, even those with a practice focus or fellowship in multiple sclerosis (MS), were not able in some cases to differentiate between MS and other common disorders, such as migraine and fibromyalgia, a new study suggests. Andrew Solomon, MD, and colleagues from the University of Vermont, Burlington, solicited and collected data from four academic centers, […]
Read MoreAmid heightened efforts to try to prevent pain and surgical patients from developing long-term opioid use or misuse, one research team has come up with a handy alternative to time-consuming screening tools for identifying patients at risk, while other researchers report on key risk factors linked to long-term use. In the first of the studies […]
Read More